More wild strains of COVID-19, without mitigation measures, are threatening an increase in spring

CDC Director Rochelle Walensky, director of the Centers for Disease Control and Prevention (CDC), speaking to National Public Radio guest Ari Shapiro expressed some concern about the coming weeks of the pandemic course that is rarely heard from senior officials. level.

“I think,” she said, “the next two or three months could go in one of two directions. If things open up, if we’re not very careful, we could go up with a post-spring hike as we’ve seen a post-Christmas surrender. We could see a lot more disease. We will see many more deaths. ”

University of Tropical Medicine virology laboratory researcher working to develop a test that detects the P.1 version of the new coronavirus, in Sao Paulo, Brazil, Thursday, March 4, 2021. (AP Photo / Andre Penner)

Similar concerns are being raised across Europe, where six million new cases were reported this week, after six weeks of steady decline, representing a 9 per cent increase over the year. -week before. Hans Kluge, head of the World Health Organisation’s (WHO) Regional Office for Europe, said on Thursday, “We are seeing a recovery in Central and Eastern European countries where standards were already high. ”

There are still major problems in the health system of the Czech Republic. Kluge urged countries to “get back to basics” public health measures. These changes in disease result from resting restraints accompanied by a growing dominance of the more active line of the coronavirus.

In the United States, according to the CDC variable map, as of March 2, 2,506 cases of B.1.1.7 variables were detected across 46 states. States where more than 100 cases have been confirmed include Florida, Michigan, New York, Georgia, Texas and California. The protective rays B.1.351 and P.1 are also increasing, but not yet at the same level.

Dr. Michael Worobey, an anthropologist at the University of Arizona, urged more attention in the United States to the P.1 variant. He raised concerns that it could become more common, even if it competes with version B.1.1.7. “At the very least, he’s going to be one of the competitors,” he told the New York Times.

These developments have damaged the optimistic hopes of many scientists when the effective COVID-19 vaccines began being used in December. The rays emanating from South Africa and Brazil prove more susceptible and damage the effect of the vaccine and, possibly, bypass the natural immunity caused by previous diseases.

.Source